Drawing for NUBEQA

USPTO serial 87812407

NUBEQA

Reviewed by CopyMark Law Group

Reg. 5584749Status 702Registered
Filing date
Status date
Registration date
Oct 16, 2018
Examiner
CHANG, ELIZABETH YI HSUAN
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with NUBEQA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Phillip Barengolts

Phillip Barengolts Pattishall, McAuliffe, Newbury, Hilliard & Geraldson LLP200 S. Wacker DriveSuite 2900Chicago, IL 60606

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of cancer(Based on 44(e)) Pharmaceutical preparations for the treatment of cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 8, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Feb 8, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Feb 8, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 17, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 17, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 17, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 26, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Oct 16, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 16, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 10, 2018DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Sep 10, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 14, 2018IUCNNOTICE OF ALLOWANCE CANCELLED—
Aug 14, 2018D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Aug 7, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 12, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 12, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 23, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 9, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 9, 2018DOCKASSIGNED TO EXAMINER—
Mar 6, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 2, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance